Low levels of C‐peptide have clinical significance for established Type 1 diabetes
WM Kuhtreiber, SLL Washer, E Hsu, M Zhao… - Diabetic …, 2015 - Wiley Online Library
Aim To determine whether the low C-peptide levels (< 50 pmol/l) produced by the pancreas
for decades after onset of Type 1 diabetes have clinical significance. Methods We evaluated
fasting C-peptide levels, duration of disease and age of onset in a large cross-sectional
for decades after onset of Type 1 diabetes have clinical significance. Methods We evaluated
fasting C-peptide levels, duration of disease and age of onset in a large cross-sectional
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论